首页> 外国专利> DERIVATIVES OF N-(2,4- OR 2,5-DISUBSTITUTED TETRAHYDROFURYLALKYL)-N-(PHENYLETHYL--OL)-AMINE IN RACEMIC OR ENANTIOMERIC FORM, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION

DERIVATIVES OF N-(2,4- OR 2,5-DISUBSTITUTED TETRAHYDROFURYLALKYL)-N-(PHENYLETHYL--OL)-AMINE IN RACEMIC OR ENANTIOMERIC FORM, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION

机译:N-(2,4-或2,5-二取代的四氢呋喃烷基)-N-(苯甲基-OL)-胺的衍生物或对映体形式,或它们的药理学上可接受的盐的衍生物,其合成方法和药物成分

摘要

FIELD: organic chemistry, medicine as agonists of b-adrenergic receptors. SUBSTANCE: product: derivatives of N-(2,4- or 2,5-disubstituted tetrahydrofurylalkyl)-N-(phenylethyl-b-ol)-amine in racenic or enantiomeric form of the formula (I) given in description text where R - b-alkyl, pyridyl, thienyl or unsubstituted phenyl or that substituted with halogen atom, C1-C10-alkoxy-group, or C1-C5-alkylsulfonyl group; n= 1-10, or their pharmaceutically acceptable salts, method of their synthesis and pharmaceutical composition prepared on their base. Reagent 1: substituted benzylamine of the formula (III) indicated in description text. Reagent 2: methyl-5-bromoacetylsalicylate. Process conditions: in the medium of protonic solvent or acetonitrile in the presence of triethylamine, at temperature from the room one to the boiling point of reaction mixture, for 2-18 hr. Reagent 3: compound of the formula (IV) indicated in description text. Reagent 4: sodium hydride as a reductant. Process conditions: in inert atmosphere, at temperature from 0 C to the room one, for 2-8 hr followed by debenzylation of synthesized compound of the formula (V) indicated in description text by hydrogenation in the presence of catalyst Pd/C or C1-C5, under pressure 2-5.5 bars, at the range of temperature from the room one to 40 C, for from 10 min to 5 hr. EFFECT: improved method of synthesis. 6 cl, 3 tbl
机译:领域:有机化学,药物作为β-肾上腺素受体激动剂。物质:产品:N-(2,4-或2,5-二取代的四氢呋喃基烷基)-N-(苯乙基-b-ol)-胺的外消旋或对映体形式的描述文字中给出的衍生物,其中R -b-烷基,吡啶基,噻吩基或未取代的苯基或被卤素原子,C 1 -C 10 -烷氧基或C 1 取代的苯基Sub> -C 5 -烷基磺酰基; n = 1-10,或其药学上可接受的盐,其合成方法和以其为基础制备的药物组合物。试剂1:描述文本中所示的式(III)的取代的苄胺。试剂2:5-溴乙酰基水杨酸甲酯。工艺条件:在质子溶剂或乙腈中,在三乙胺存在下,在室温至室温至反应混合物沸点的温度下进行2-18小时。试剂3:描述文本中所示的式(IV)的化合物。试剂4:氢化钠作为还原剂。工艺条件:在惰性气氛中,在0℃至室温的温度下,进行2-8小时,然后在催化剂Pd / C或C的存在下通过氢化使描述文字所示的式(V)的合成化合物脱苄基 1 -C 5 ,在2-5.5巴的压力下,在室温1至40 C的温度范围内,持续10分钟至5小时。效果:改进的合成方法。 6厘升,3汤匙

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号